ONYX PHARMACEUTICALS INC Deferred Tax Assets, Net of Valuation Allowance
ONYX PHARMACEUTICALS INC had Deferred Tax Assets, Net of Valuation Allowance of $123.69 million as of 2012-12-31, per its 10-K filed 2013-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2013-02-28
- 2012-12-31: Deferred Tax Assets, Net of Valuation Allowance $123.69M.
- 2011-12-31: Deferred Tax Assets, Net of Valuation Allowance $36.69M; Deferred Tax Assets, Net of Valuation Allowance as first filed $36.69M.
- 2010-12-31: Deferred Tax Assets, Net of Valuation Allowance $39.53M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2012-12-31 | $123.69M 10-K · filed 2013-02-28 | |
| 2011-12-31 | $36.69M 10-K · filed 2013-02-28 | $36.69M 10-K · filed 2012-02-27 |
| 2010-12-31 | $39.53M 10-K · filed 2012-02-27 |